Researchers develop techniques to bypass blood-brain barrier, deliver drugs to brain and nervous system

October 20, 2015 by Suzanne Day
Drugs used to treat a variety of central nervous system diseases may be administered through the nose and diffused through an implanted mucosal graft (A, in red) to gain access to the brain. Under normal circumstances, there are multiple layers within the nose that block the access of pharmaceutical agents from getting to the brain including bone and the dura/arachnoid membrane, which represents part of the blood-brain barrier (B). After endoscopic skull base surgery (C), all of these layers are removed and replaced with a nasal mucosal graft, which is 1,000 times more porous than the native blood-brain barrier. Consequently, these grafts may be used to deliver very large drugs, including proteins, which would otherwise be blocked by the blood-brain barrier. Credit: Garyfallia Pagonis and Benjamin S. Bleier, M.D.

Researchers at Massachusetts Eye and Ear/Harvard Medical School and Boston University have successfully prevented the development of Parkinson's disease in a mouse using new techniques to deliver drugs across the naturally impenetrable blood-brain barrier. Their findings, published in Neurosurgery, lend hope to patients around the world with neurological conditions that are difficult to treat due to a barrier mechanism that prevents approximately 98 percent of drugs from reaching the brain and central nervous system.

"We are developing a platform that may eventually be used to deliver a variety of drugs to the brain," said senior author Benjamin S. Bleier, M.D., of the department of otolaryngology at Mass. Eye and Ear/Harvard Medical School. "Although we are currently looking at neurodegenerative disease, there is potential for the technology to be expanded to psychiatric diseases, chronic pain, seizure disorders and many other conditions affecting the brain and down the road."

Using nasal mucosal grafting, researchers delivered glial derived neurotrophic factor (GDNF), a known therapeutic protein for treating Parkinson's disease, to the brains of mice. They showed through behavioral and histological data capture that their was equivalent to direct injection of GDNF - the current gold standard for delivering this drug in Parkinson's disease despite its traumatic nature and high complication rates - in diffusing drugs to the brain.

The researchers chose to test their delivery method with GDNF because the therapy has been shown to delay and even reverse disease progression of Parkinson's disease.

Nasal mucosal grafting is a technique regularly used in the ENT field to reconstruct the barrier around the brain after surgery to the skull base. ENT surgeons commonly use endoscopic approaches to remove brain tumors through the nose by making a window through the blood-brain barrier to access the brain. Once they have finished the treatment, they use adjacent nasal lining to rebuild the hole in a permanent and safe way. The safety and efficacy of these methods have been well established through long-term clinical outcomes studies in the field, with the nasal lining protecting the brain from infection just as the has done.

Dr. Bleier saw an opportunity to apply these techniques to the widespread clinical dilemma of delivering drugs across the barrier to the brain and central nervous system. By functionally replacing a section of the with nasal mucosa, which is more than 1,000 times more permeable than the native barrier, surgeons may create a "screen door" to allow for drug delivery to the brain and central nervous system.

The technique has the potential to benefit a large population of patients with neurodegenerative disorders, where there remains a specific unmet need for blood-brain penetrating therapeutic delivery strategies.

"We see this expanding beyond Parkinson's disease, as there are multiple diseases of the that do not have good therapeutic options," Dr. Bleier said. "It is a platform that opens doors for new discovery and could enable drug development for an underserved population."

Explore further: Researchers use nasal lining to breach blood-brain barrier

Related Stories

Researchers use nasal lining to breach blood-brain barrier

April 24, 2013

Neurodegenerative and central nervous system (CNS) diseases represent a major public health issue affecting at least 20 million children and adults in the United States alone. Multiple drugs exist to treat and potentially ...

Recommended for you

New trial for prosthetic hip joint infection

June 14, 2017

The first ever randomised trial to investigate why some patients develop infections after their hip or knee replacement surgery, and which type of surgical revision treatment is best is being run by the University of Bristol ...

Making prosthetic limbs feel more natural

May 31, 2017

A new surgical technique devised by MIT researchers could allow prosthetic limbs to feel much more like natural limbs. Through coordination of the patient's prosthetic limb, existing nerves, and muscle grafts, amputees would ...

A good night's sleep rests on your spine's biomechanics

May 22, 2017

A three-year study by QUT biomedical researchers in the Paediatric Spine Research Group (PSRG) aims to deepen our understanding of the concepts of comfort by using new techniques to look at how the spine reacts in different ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.